Irritable Bowel Syndrome - Diarrhea (IBS-D) is a chronic functional gastrointestinal (GI) disorder. IBS-D patients frequently experience belly pain associated with defecation, change in stool frequency and/or form, unpredictable bowel movement and sudden urge to use the bathroom.
IBS-D is normally diagnosed through a medical history and physical exam. If you experience diarrhea, abdominal pain, bloating, gas and uncontrolled bowel movements for at least 3 months, you might have IBS-D.
IBS-D is more likely to affect women than men and more common in adults under 50. Even though IBS-D is non-fatal, it can have a negative effect on patient’s quality of life. The unpredictable urge and abdominal pain may prevent you from having an active social life, taking a vacation, or enjoying meals without worry. Although IBS-D is un-curable, IBS-D can be managed with treatments to alleviate the abdominal pain and improve life quality.
Before you are evaluated as a research participant, we will provide you with an approved Informed Consent Form (ICF) which you must read, understand, and sign before enrolling. The ICF outlines all procedures you will need to go through and all known risks and side effects of the investigational medication. Please read it carefully and ask all questions you might have.
Additionally, both FDA (www.fda.gov) and National Institute of Health (www.ClinicalTrials.gov ) maintain databases of clinical trials conducted in the US. All trials conducted by BCT are registered with FDA. If you need help finding information about a trial that you’d like to learn about, please do not hesitate to ask our staff.
Before conducting a clinical trial, pharmaceutical companies must obtain approval from the FDA to ensure that the investigational medication is appropriate to give to people.
Additionally, all study procedures are reviewed by an independent Investigational Review Board (IRB) before they are allowed to be administered. All this is done to ensure that the study is ethical and that the risks are as low as possible. However, since the study participants are among the first to try the investigational medication, the risk of unanticipated side effects does exist. This is why the health of the people participating in the trials is continuously monitored and any serious side effects experienced by any of the people in the trial are promptly investigated. If necessary, corrective actions, including termination of the trial, are taken.
Different studies have different enrollment requirements. Some studies are open only to healthy adults, other look for people with specific medical conditions, for instance, anxiety, depression, migraines, sexual dysfunction, etc. To determine whether you can enroll, we will ask several questions about your current health, your medical condition, and the medications you are taking. If you meet the study requirements, an appointment will be schedule for you to be evaluated in person.
Never. Any information you provide as a research participant is strictly confidential. It will not be sold and will be used only for the purposes of contacting you for relevant research studies